Publications
129
Citations
3,972
Est. group size
—
Recurring co-author estimate
Active years
33
Publishing since 1994
Greg T. Sutherland studies the brain changes underlying Alzheimer's disease and alcohol use disorder, using post-mortem human brain tissue, brain banking infrastructure, and molecular techniques such as genomics, transcriptomics, and immunohistochemistry. His work spans basic mechanisms (e.g., amyloid pathology, neuroinflammation, glial gene dysregulation) as well as practical methods and resources for brain tissue research, including biobanking protocols and cross-institutional brain bank networks.
Publication output has grown over the past decade, rising from about 5-8 papers per year in 2017-2019 to a peak of around 13-14 per year in 2023-2024, with a slight decline in 2025-2026 (partial year data).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- An Australian brain bank and the future of alcohol and major neuropsychiatric disorders research
Frontiers in Neurology · 2026
- Antibody elution methods for multiplex immunofluorescence of Alzheimer's disease pathology in human post-mortem brain tissue
Frontiers in Neurology · 2026
- Developing an integrated brain resource framework for translational neuroscience in Korea Brain Bank
Frontiers in Neurology · 2026
- Integrative Genomics Approach Identifies Glial Transcriptomic Dysregulation and Risk in the Cortex of Individuals With Alcohol Use Disorder
Biological Psychiatry · 2025
- Quantification of Alzheimer disease neuropathology using tissue microarrays
Journal of Neuropathology & Experimental Neurology · 2025
- Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline
Alzheimer s & Dementia · 2025
- Physical activity, genetic predisposition, and incident cardiovascular disease: Prospective analyses of the UK Biobank
Journal of sport and health science/Journal of Sport and Health Science · 2025
- Dual Stages of Alcohol-Related Cerebral White Matter Degeneration Reviewed: Early-Stage Stress/Neuroinflammation Versus Late-Stage Impaired Insulin/IGF Signaling Through Akt-mTOR–Review
ASN NEURO · 2025
- Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep: Potential implications for therapeutic targets in Alzheimer's disease
Neurobiology of Aging · 2025
- CoREST3 exhibits isoform specific expression in Alzheimer’s disease and regulation of HDAC2
BMC Biology · 2025
- A systematic review and meta-analysis on the transcriptomic signatures in alcohol use disorder
Molecular Psychiatry · 2024
- Increased Neuronal Nitric Oxide Synthase in Alzheimer's Disease Mediates Spontaneous Calcium Signaling and Divergent Glutamatergic Calcium Responses
Antioxidants and Redox Signaling · 2024
- Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorder
Alcohol Clinical and Experimental Research · 2024
- The Experts Speak: Challenges in Banking Brain Tissue for Research
Biopreservation and Biobanking · 2024
- Post-mortem human brain analysis of the ventral pallidum in alcohol use disorder
Addiction Neuroscience · 2024
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Scientific Reports×5
- Alcohol×5
- Alzheimer s & Dementia×4
- Research Square×3
- Jungsu Kim
Medicine · Indiana University
- Bruce T. Lamb
Medicine · Indiana University
- Adrian L. Oblak
Medicine · Indiana University
- Brendan K. Ball
Medicine · Purdue University West Lafayette
- Diana Acosta
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile